Presentation of lung cancer in primary care
| Autor: | David Weller, M. D. Peake, John K. Field |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2019 |
| Předmět: |
Pulmonary and Respiratory Medicine
medicine.medical_specialty Lung Neoplasms media_common.quotation_subject Disease Primary care Review Article Risk Assessment Late presentation 03 medical and health sciences Presentation 0302 clinical medicine Respiratory signs and symptoms medicine Humans 030212 general & internal medicine Lung cancer Intensive care medicine Physician's Role Signs and symptoms Referral and Consultation Early Detection of Cancer media_common lcsh:RC705-779 Primary Health Care business.industry Public Health Environmental and Occupational Health lcsh:Diseases of the respiratory system medicine.disease 030228 respiratory system Critical Pathways Smoking Cessation Lung tumours business Lung cancer screening |
| Zdroj: | NPJ PRIMARY CARE RESPIRATORY MEDICINE npj Primary Care Respiratory Medicine, Vol 29, Iss 1, Pp 1-5 (2019) NPJ Primary Care Respiratory Medicine Weller, D P, Peake, M D & Field, J K 2019, ' Presentation of lung cancer in primary care ', npj Primary Care Respiratory Medicine, vol. 29, no. 1, pp. 21 . https://doi.org/10.1038/s41533-019-0133-y |
| DOI: | 10.1038/s41533-019-0133-y |
| Popis: | Survival from lung cancer has seen only modest improvements in recent decades. Poor outcomes are linked to late presentation, yet early diagnosis can be challenging as lung cancer symptoms are common and non-specific. In this paper, we examine how lung cancer presents in primary care and review roles for primary care in reducing the burden from this disease. Reducing rates of smoking remains, by far, the key strategy, but primary care practitioners (PCPs) should also be pro-active in raising awareness of symptoms, ensuring lung cancer risk data are collected accurately and encouraging reluctant patients to present. PCPs should engage in service re-design and identify more streamlined diagnostic pathways—and more readily incorporate decision support into their consulting, based on validated lung cancer risk models. Finally, PCPs should ensure they are central to recruitment in future lung cancer screening programmes—they are uniquely placed to ensure the right people are targeted for risk-based screening programmes. We are now in an era where treatments can make a real difference in early-stage lung tumours, and genuine progress is being made in this devastating illness—full engagement of primary care is vital in effecting these improvements in outcomes. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|